Glucose Measurement Using Microneedle Patches
NCT02682056 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2020-01-03
Summary
This study will compare three glucose measurement techniques among diabetic children and adolescents. The study seeks to determine if a microneedle patch (made from biocompatible polymers or metal), versus a lancet or intravenous catheter, would be a preferable option for monitoring glucose levels among the diabetic pediatric population.
Conditions
Interventions
- DEVICE
-
Microneedle patch
The microneedle patch will collect interstitial fluid to be tested for glucose level. The microneedles are made from biocompatible polymers or metal. Participants will have fasting glucose levels measured four times, on an hourly basis, during the study visit.
- DEVICE
-
Intravenous (IV) catheter
The intravenous (IV) catheter will collect venous blood to be tested for glucose level. Participants will have fasting glucose levels measured four times, on an hourly basis, during the study visit.
- DEVICE
-
Lancet
The lancet will collect capillary blood to be tested for glucose level. Participants will have fasting glucose levels measured four times, on an hourly basis, during the study visit.
Sponsors & Collaborators
-
Emory University
lead OTHER
Principal Investigators
-
Eric Felner, MD · Emory University
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 7 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-21
- Primary Completion
- 2018-01-29
- Completion
- 2018-01-29
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Glycemic Control and the Brain in Children With Type 1 Diabetes
NCT03428932 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the MiniMed 780 System in Paediatric Subjects
NCT05574062 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study to Assess the Safety, PK and PD of Insulin Injected Via MicronJet or Conventional Needle
NCT00602914 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of the InsuPatch on Automated Closed-loop Glucose Control in Type 1 Diabetes
NCT01787318 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Optimizing Metabolic Control in Type 1 Diabetes - The Automatic Bolus Calculator Flash Study
NCT03682237 ·Status: COMPLETED ·Phase: NA
-
Hybrid Closed Loop in High Risk Youth With Type 1 Diabetes
NCT04807374 ·Status: COMPLETED ·Phase: NA
-
Omnipod Horizon™ Automated Glucose Control System Preschool Cohort
NCT04476472 ·Status: COMPLETED ·Phase: NA
-
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
NCT00441129 ·Status: COMPLETED ·Phase: NA
-
The MiniMed™ 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects With Type 1 Diabetes in France.
NCT04308291 ·Status: COMPLETED
-
Automated Closed-loop in Children and Adolescents With Type 1 Diabetes
NCT02129868 ·Status: COMPLETED ·Phase: NA
-
Tissue-Specific Metabolic Reprogramming in Diabetic Complications
NCT01823406 ·Status: COMPLETED ·Phase: NA
-
Study of Insulin Therapy Augmented by Real Time Sensor IN Type 1 Children and Adolescents (START-IN!)
NCT00949221 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
CGM Use in Poorly Controlled Youth With Type 1 Diabetes
NCT04721145 ·Status: COMPLETED ·Phase: NA
-
Continue Glucose Monitoring Before Insulin Pump
NCT02813421 ·Status: COMPLETED ·Phase: NA
-
Glycemic Outcomes and Safety With Minimed 780G System in Children With Type 1 Diabetes Aged 2-6 Years
NCT04949022 ·Status: UNKNOWN ·Phase: NA
-
Blood Glucose Variability and Insulin Action During Menstrual Cycle in Females With Type 1 Diabetes
NCT02693938 ·Status: COMPLETED ·Phase: NA
-
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
NCT06181721 ·Status: COMPLETED ·Phase: NA
-
De-tensioning Patch, in Subjects With Type 1 Diabetes and Lipohypertrophy
NCT06025513 ·Status: COMPLETED ·Phase: NA
-
CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections
NCT02092051 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Effect of Smart Insulin Pens on Glycemic Control and Diabetes-related Burdens
NCT05036343 ·Status: COMPLETED ·Phase: NA
-
Long Term CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections
NCT02465411 ·Status: COMPLETED ·Phase: NA
-
Patient Preference of h-Patch vs. Pen or Needle/Syringe as Insulin Administration Device
NCT00453934 ·Status: TERMINATED ·Phase: PHASE4
-
Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting
NCT01755416 ·Status: COMPLETED ·Phase: PHASE2
-
Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients
NCT03463564 ·Status: RECRUITING ·Phase: PHASE4
-
Insulin Clamp Ancillary Study for Assessment of Insulin Resistance
NCT02045290 ·Status: COMPLETED ·Phase: PHASE3